QuidelOrtho Explodes: 40% Increase After Numbers Release
Reading Time: 2 minutes
QuidelOrtho Corporation is a global leader in the field of in-vitro diagnostics, headquartered in the USA. Formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics in May 2022, the company combines over 80 years of experience in the development and manufacture of diagnostic solutions. With a broad product portfolio that includes brands such as Sofia®, QuickVue®, VITROS®, and Savanna®, QuidelOrtho serves various sectors, including molecular diagnostics, clinical chemistry, and transfusion medicine. The company employs approximately...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
